Removing lymph nodes (axillary dissection) was considered the norm for breast cancer treatment for decades, until a controversial trial proved that women did not need to undergo the invasive surgery. A new study has followed up the women ten years on, and found survival is comparable between women who receive axillary dissection and those that don’t.

Guest Andrew Spillane

Professor of Surgical Oncology at the University of Sydney

Presenter Dr Norman Swan